Agribiotech International Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 09600103 (England and Wales)

AGRIBIOTECH INTERNATIONAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr R Calcagni

Mr G Calcagni

REGISTERED OFFICE:

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

REGISTERED NUMBER:

09600103 (England and Wales)

ACCOUNTANTS:

Christiansons Ltd

Chartered Certified Accountants

Sterling House

Fulbourne Road

Walthamstow

London

E17 4EE

FIXED ASSETS

Intangible assets

4

152,713

180,478

Tangible assets

5

78,251

92,060

Investments

6

2,784,420

3,015,384

3,056,958

CURRENT ASSETS

Stocks

7

8,100

52,692

Debtors

8

1,458,944

1,699,397

Cash at bank and in hand

102,502

32,288

1,569,546

1,784,377

CREDITORS

Amounts falling due within one year

9

610,135

583,054

NET CURRENT ASSETS

959,411

1,201,323

TOTAL ASSETS LESS CURRENT
LIABILITIES

3,974,795

4,258,281

CAPITAL AND RESERVES

Called up share capital

10

5,200,000

Retained earnings

11

(1,225,205

)

(941,719

)

SHAREHOLDERS' FUNDS

3,974,795

4,258,281

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 June 2026 and were signed on its behalf by:

Mr G Calcagni - Director

1.	STATUTORY INFORMATION

Agribiotech International Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Know how and licences

Know how and licences is amortised over the estimated life of the asset of eight years.

Development costs

Development costs is amortised over the estimated life of the asset of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Buildings and structures

-

15% on reducing balance

Investments in subsidiaries and associates

Investments in subsidiary and associate undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	INTANGIBLE FIXED ASSETS

Development

Know how

costs

Totals

£

COST

At 1 January 2025

and 31 December 2025

73,145

314,676

387,821

AMORTISATION

At 1 January 2025

73,145

134,198

207,343

Amortisation for year

-

27,765

At 31 December 2025

73,145

161,963

235,108

NET BOOK VALUE

At 31 December 2025

-

152,713

At 31 December 2024

-

180,478

5.	TANGIBLE FIXED ASSETS

Buildings

and

structures

£

COST

At 1 January 2025

and 31 December 2025

265,289

DEPRECIATION

At 1 January 2025

173,229

Charge for year

13,809

At 31 December 2025

187,038

NET BOOK VALUE

At 31 December 2025

78,251

At 31 December 2024

92,060

6.	FIXED ASSET INVESTMENTS

31.12.25

31.12.24

£

Shares in group undertakings

2,018,849

Participating interests

290,454

Other investments not loans

475,117

2,784,420

Additional information is as follows:

Shares in

Interest

group

in joint

undertakings

venture

Totals

£

COST

At 1 January 2025

and 31 December 2025

2,018,849

290,454

2,309,303

NET BOOK VALUE

At 31 December 2025

2,018,849

290,454

2,309,303

At 31 December 2024

2,018,849

290,454

2,309,303

Investments (neither listed nor unlisted) were as follows:

31.12.25

31.12.24

£

Orchards Cost/valuation

475,117

327,272

Orchards Addition

-

147,845

475,117

7.

STOCKS

31.12.25

31.12.24

£

Stocks

8,100

52,692

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

Trade debtors

533,601

576,150

Amounts owed by group undertakings

787,032

953,055

Other debtors

68

72

Prepayments and accrued income

138,243

170,120

1,458,944

1,699,397

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

Trade creditors

69,680

223,510

Corporation tax

3,618

-

Directors' current accounts

535,137

358,004

Accruals and deferred income

1,700

1,540

610,135

583,054

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.25

31.12.24

value:

£

47,000,000

Ordinary

10p

4,700,000

3,500,000

Ordinary A

10p

350,000

1,500,000

Ordinary B

10p

150,000

5,200,000

11.

RESERVES

Retained

earnings

£

At 1 January 2025

(941,719

)

Deficit for the year

(283,486

)

At 31 December 2025

(1,225,205

)